However, this assertion is largely contingent on the hypothesis that sephin1 failed to modulate PERK activity in the ALS model, given that the authors demonstrated that sephin1 did not affect the expression of ATF4 in their study [115]. Here, ATF4 is linked to amyotrophic lateral sclerosis.